Invention Grant
- Patent Title: Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
-
Application No.: US13747052Application Date: 2013-01-22
-
Publication No.: US08580806B2Publication Date: 2013-11-12
- Inventor: Paul W Manley , Wen-Chung Shieh , Paul Allen Sutton , Piotr H Karpinski , Raeann Wu , Stéphanie Monnier , Jörg Brozio
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Stephen Johnson
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61P35/00 ; C07D401/14
![Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide](/abs-image/US/2013/11/12/US08580806B2/abs.jpg.150x150.jpg)
Abstract:
Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide are prepared by various processes.
Public/Granted literature
Information query
IPC分类: